266 related articles for article (PubMed ID: 17365852)
1. Platelets possess functional TGF-beta receptors and Smad2 protein.
Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
[TBL] [Abstract][Full Text] [Related]
2. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
4. Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
Kao YH; Jawan B; Goto S; Pan MC; Lin YC; Sun CK; Hsu LW; Tai MH; Cheng YF; Nakano T; Wang CS; Huang CJ; Chen CL
Cytokine; 2009 Jul; 47(1):11-22. PubMed ID: 19457680
[TBL] [Abstract][Full Text] [Related]
5. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
Wang J; Albertson CM; Zheng H; Fink LM; Herbert JM; Hauer-Jensen M
Thromb Haemost; 2002 Jan; 87(1):122-8. PubMed ID: 11848440
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
7. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
Fukuda M; Kurosaki H; Sairenji T
J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
Kuemmerle JF; Murthy KS; Bowers JG
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G795-802. PubMed ID: 15178549
[TBL] [Abstract][Full Text] [Related]
9. The core-aldehyde 9-oxononanoyl cholesterol increases the level of transforming growth factor beta1-specific receptors on promonocytic U937 cell membranes.
Gargiulo S; Gamba P; Sottero B; Biasi F; Chiarpotto E; Serviddio G; Vendemiale G; Poli G; Leonarduzzi G
Aging Cell; 2009 Apr; 8(2):77-87. PubMed ID: 19302374
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.
Peraçoli MT; Menegon FT; Borges VT; de Araújo Costa RA; Thomazini-Santos IA; Peraçoli JC
J Reprod Immunol; 2008 Oct; 79(1):79-84. PubMed ID: 18805591
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
[TBL] [Abstract][Full Text] [Related]
12. Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells.
Moon HJ; Jeon ES; Kim YM; Lee MJ; Oh CK; Kim JH
Int J Biochem Cell Biol; 2007; 39(6):1224-34. PubMed ID: 17481939
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
14. Lateral diffusion of TGF-beta type I receptor studied by single-molecule imaging.
Ma X; Wang Q; Jiang Y; Xiao Z; Fang X; Chen YG
Biochem Biophys Res Commun; 2007 Apr; 356(1):67-71. PubMed ID: 17346672
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.
Vega JL; Puebla C; Vásquez R; Farías M; Alarcón J; Pastor-Anglada M; Krause B; Casanello P; Sobrevia L
Cardiovasc Res; 2009 Jun; 82(3):458-67. PubMed ID: 19193655
[TBL] [Abstract][Full Text] [Related]
16. ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability.
Birukova AA; Adyshev D; Gorshkov B; Birukov KG; Verin AD
FEBS Lett; 2005 Jul; 579(18):4031-7. PubMed ID: 16004987
[TBL] [Abstract][Full Text] [Related]
17. Latent TGF-beta1 activation by platelets.
Blakytny R; Ludlow A; Martin GE; Ireland G; Lund LR; Ferguson MW; Brunner G
J Cell Physiol; 2004 Apr; 199(1):67-76. PubMed ID: 14978736
[TBL] [Abstract][Full Text] [Related]
18. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1.
Eligini S; Barbieri SS; Arenaz I; Tremoli E; Colli S
Cardiovasc Res; 2007 May; 74(2):270-8. PubMed ID: 17250815
[TBL] [Abstract][Full Text] [Related]
19. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
20. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
